AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

about

Systemic IGF-1 gene delivery by rAAV9 improves spontaneous autoimmune peripheral polyneuropathy (SAPP).Hepatocyte Growth Factor (HGF) Promotes Peripheral Nerve Regeneration by Activating Repair Schwann Cells.Efficacy of exogenous pyruvate in Trembler mouse model of Charcot-Marie-Tooth neuropathy

P2860

Q54242491-C0E3269A-20AC-4D71-867A-552442165E86 Q55334232-C2541450-FE3C-4291-9AC3-8711DF5FF8EE Q58702974-1AFD5F2A-51B6-4990-B502-C4D46D13537B

P2860

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

Item

http://www.wikidata.org/entity/Q36418552

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@ast

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@en

type

Item

label

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@ast

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@en

prefLabel

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@ast

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@en

P1476

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

@en

P2093

C Braganza

http://www.w3.org/2001/XMLSchema#string

J R Mendell

http://www.w3.org/2001/XMLSchema#string

L Chen

http://www.w3.org/2001/XMLSchema#string

W D Arnold

http://www.w3.org/2001/XMLSchema#string

Z Sahenk

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

The trk family of tyrosine protein kinase receptors

Expression of Trk receptors in the developing mouse trigeminal ganglion: in vivo evidence for NT-3 activation of TrkA and TrkB in addition to TrkC

AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.

Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data.

Combined scatter diagrams of sheath thickness and fibre calibre in human sural nerves: changes with age and neuropathy

VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy.

Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.

P2888

gt.2015.67

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2015.67

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mehmet Emir Yalvac

P577

2015-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050523574

http://www.w3.org/2001/XMLSchema#string

P698

26125608

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4696906

http://www.w3.org/2001/XMLSchema#string

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

about

P2860

P2860

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932